/policies/,/policies/clinical/,/policies/clinical/uwhc-clinical/,/policies/clinical/uwhc-clinical/department-specific/,/policies/clinical/uwhc-clinical/department-specific/pharmacy/,/policies/clinical/uwhc-clinical/department-specific/pharmacy/drug-policy/,

/policies/clinical/uwhc-clinical/department-specific/pharmacy/drug-policy/1322.policy

201410290

page

100

UWHC,

Policies,Clinical,UWHC Clinical,Department Specific,Pharmacy,Drug Policy

Drug Product Selection and Supply Subcommittee (13.22)

Drug Product Selection and Supply Subcommittee (13.22) - Policies, Clinical, UWHC Clinical, Department Specific, Pharmacy, Drug Policy

13.22





Effective Date:

May 2005
⌧ Pharmacy Policy Manual
Chapter: Drug Policy
Operations Procedure Manual
Chapter

Policy #: 13.22

Original
⌧ Revision 4/14
Page 1
of 2
Title: Drug Product Selection and Supply
Subcommittee


I. PURPOSE: To ensure that formulary medications are stocked in appropriate dosage forms,
strengths and quantities by the University of Wisconsin Hospital and Clinics (UWHC) Department
of Pharmacy.

II. POLICY: The Drug Product Selection and Supply (DPSS) Subcommittee, a subcommittee of
the Pharmacy and Therapeutics (P&T) Committee, selects the dosage forms, strengths and quantities
of formulary medication to be stocked at UWHC. The DPSS subcommittee has oversight and
responsibility for line item extensions, dispensing locations, automated dispensing cabinet and
(ADC) override lists.

III. PROCEDURE:
A. DPSS Subcommittee:
1. Members of the DPSS Subcommittee will be appointed by the Director of Pharmacy
and will include representatives from the Drug Policy Program, Central Pharmacy /
Sterile Products Area, Decentral Pharmacy units, Clinic Pharmacy, and the
Medication Management team.
2. The committee meets regularly on a monthly basis with the meeting organized
according to a prespecified agenda
B. Designated Activities
1. Continuous review of drug shortages.
a. A weekly update containing shortage information will be sent to key medical
and pharmacy staff.
b. The chairperson makes contacts as necessary to develop strategy for
managing shortages – see Pharmacy Policy 9.13.
2. Select specific products among formulary medications according to the following
criteria:
a. Bioequivalency
b. Consistent availability
c. Product acceptance
d. Product problems and recall history
3. Review requests for stocked formulary medications
a. Review for appropriate stocking on hospital units, in AcuDose machines or
clinics.
b. Compare to other stocked items to minimize duplication





Effective Date:

May 2005
⌧ Pharmacy Policy Manual
Chapter: Drug Policy
Operations Procedure Manual
Chapter

Policy #: 13.22

Original
⌧ Revision 4/14
Page 2
of 2
Title: Drug Product Selection and Supply
Subcommittee

c. Assess safety implications
d. Determine storage requirements and space limitations
e. Identify look-alike sound-alike medication concerns and necessary actions
f. Determine the cost-effectiveness of stocking with regard to:
i. Frequency of Use
ii. Shelf-life
iii. Cost
iv. Portability from central pharmacy
g. Estimate the appropriate quantity for stock
C. Review requests for new dosage forms or strengths of formulary medications i.e. line-
extensions.
D. Review requests for AcuDose-Rx override changes with regard to
1. The medication and need for emergent supply
2. Safety issues
E. Review of drugs with low frequency of use
1. Review unit floor stock annually with goal of removing drugs or formulations used
infrequently.
2. The chairperson calls upon pharmacists to facilitate the review with staff physicians
and services that utilize the drug.
3. Medications on the permanent low use list are exempt since they must remain on the
formulary (e.g., poison antidotes).
4. Recommendations for deletion are forwarded to the P&T Committee for review and
approval.
F. Assess impact of floor stock additions or deletions on the electronic medical record and
drug storage cabinets.
G. Meeting minutes are reviewed by the P&T Committee on a monthly basis.



Approved By: ____________________________
Director of Pharmacy Services

Date: ____________